Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
The (sometimes) overnight pharmacist
Sleep is a hot topic for pharmacist Anousheh Page MPS, Director of Pharmacy at Brisbane’s only 24-hour pharmacy.
What pharmacists learnt in 2021
The last year has been one of the most challenging to date. But as these stories highlight, pharmacists have continued to improve the lives of Australians throughout the pandemic.
Victorians face another week of restrictions
Victoria will join South Australia and Western Australia in requiring all people entering a pharmacy to check in using a QR code from Friday.
Excellence awards for standout pharmacists
The first Aboriginal registered pharmacist, a hard-working mother and two industry pioneers were recognised with excellence awards at PSA22.
Industry-wide change needed to combat climate change
Collaboration between the health sector and governments is essential to reducing the negative health impacts of climate change.
PSA to develop education standards for CPD activities
With the Australian Pharmacy Council retiring its accreditation standards for CPD activities, PSA is set to step up.
